1 – 46 of 46
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities : further results from the prospective PANTHER study with focus on obese patients
2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(1). p.109-114(
- Contribution to journal › Article
- 2016
-
Mark
No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT
(
- Contribution to journal › Article
- 2014
-
Mark
Abstract P2-11-15: Immunohistochemical assessment of Ki67 with the antibodies SP6 and MIB1 - A comparison of prognostic information and reproducibility
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-10-07: Stem cell marker aldehyde dehydrogenase 1 in stromal cells strongly correlates with prognosis in breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
A Prognostic Index Composed of Progesterone Receptor Status, Tumour Size and S-phase Fraction, Predicts Survival in Node-Negative Breast Cancer Patients in a Large Multicentre Prospective Cohort Study.
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-10-19: Are the mitotic factors Mitotic Activity Index (MAI) and Phosphohistone 3 (PPH3) stronger prognostic proliferation factors than Ki67 in node-negative breast cancer?
(
- Contribution to journal › Published meeting abstract
-
Mark
G protein-coupled estrogen receptor in the plasma membrane is prognostic in early breast cancer
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
(
- Contribution to journal › Article
- 2011
-
Mark
COMPLICATIONS AFTER CYSTECTOMY AND ILEAL CONDUIT FOR BLADDER CANCER IS MORE COMMON IN SMALL VOLUME HOSPITALS
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.43-43(
- Contribution to journal › Published meeting abstract
-
Mark
431 INITIAL BCG INSTILLATION IS UNDER-USED IN T1 BLADDER CANCER
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.148-148(
- Contribution to journal › Published meeting abstract
-
Mark
P4-09-02: G Protein-Coupled Estrogen Receptor 1 Positively Correlates with Estrogen Receptor a Expression and Increased Distant Disease-Free Survival of Breast Cancer Patients.
(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Abstract P4-11-01: Cardiovascular Effects of Postmastectomy Irradiation Evident after 15 Years. Results from the South Sweden Breast Cancer Group's Randomised Studies SBII:1 with 25 Years of Follow-Up of Pre-and Postmenopausal Women with Stage II Breast Cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Cyclin A - an alternative to gene expression profiling for subdividing histological grade 2 breast cancer into groups with different prognosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-Term Follow-Up of SweBCG 91RT, a Randomized Trial of Breast Conservation Surgery with and without Radiotherapy from the Swedish Breast Cancer Group
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Establishment and implementation of common guidelines for 3D treatment planning for breast cancer in southern and western Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
SORENESS AND SENSITIVITY TO SUN EXPOSURE 10 TO 16 YEARS AFTER BREAST CANCER RADIOTHERAPY
(
- Contribution to journal › Published meeting abstract
- 2006
-
Mark
Time dependent effects of tamoxifen treatment on cardiovascular morbidity
(
- Contribution to journal › Published meeting abstract
- 2005
-
Mark
The cost-effectiveness of post-operative radiotherapy after breast conservation surgery in stage I-II breast cancer in Sweden
(
- Contribution to journal › Published meeting abstract
- 2003
-
Mark
Prolonged tamoxifen therapy; effects on contralateral breast cancer, endometrial cancer incidence and cardiovascular mortality
(
- Contribution to journal › Published meeting abstract
- 2001
-
Mark
DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase) : association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients
(
- Contribution to journal › Article
-
Mark
Image cytometric Auer class-I identifies a real low risk group among lymph node negative premenopausal breast cancer patients
(
- Contribution to journal › Published meeting abstract
-
Mark
Timing of quality of life (QoL) assessments as a source of error in oncological trials
(
- Contribution to journal › Article
- 2000
-
Mark
ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(12). p.1545-1550(
- Contribution to journal › Article
-
Mark
A randomised study of sector resection with and without radiotherapy for women with node-negative stage I and II breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group
(
- Contribution to journal › Article
- 1999
-
Mark
Predictive value of P53, MDM-2, P21-expression, KI-67 for response to docetaxel or methotrexate-fluorouracil (MF) in advanced breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Predictive value c-erB-B2 expression for response to docetaxel (D) or methotrexate-fluorouracil (MF) in advanced breast cancer
(
- Contribution to journal › Published meeting abstract
- 1998
-
Mark
Urokinase plasminogen activator and flow cytometric S-phase fraction as prognostic indicators in breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
A dose intensity study of epirubicin weekly for disseminated breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411(
- Contribution to journal › Article
-
Mark
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
(
- Contribution to journal › Article
- 1997
-
Mark
SBU har fel om strålbehandling vid hjärntumör. Snar postoperativ terapi förlänger symtomfri tid
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 1995
-
Mark
CAVIAR : a tool to improve serial analysis of the 12-lead electrocardiogram
(
- Contribution to journal › Article
- 1985
-
Mark
Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine
(
- Contribution to journal › Article
- 1983
-
Mark
Column separation of monocytes by adherence to gelatin beads
(
- Contribution to journal › Article
- 1982
-
Mark
Natural killer cell activity and antibody-dependent cellular cytotoxicity in newborn infants
(
- Contribution to journal › Article
- 1981
-
Mark
ANAE staining pattern of rat lymphocytes : lack of correlation with lymphocyte subclasses
(
- Contribution to journal › Article
- 1980
-
Mark
A study of natural killer (NK) cell activity and antibody-dependent cellular cytotoxicity (ADCC) in newborn infants
(
- Contribution to journal › Published meeting abstract
-
Mark
Countercurrent distribution of lymphocytes from human peripheral blood in an aqueous two-phase system. : II. Separation into subsets of lymphocytes with distinctive functions
(
- Contribution to journal › Article
-
Mark
Countercurrent Distribution of Lymphocytes from Human Peripheral Blood in an Aqueous Two-Phase System : I. Separation into Subsets of Lymphocytes Bearing Distinctive Markers’
(
- Contribution to journal › Article
- 1979
-
Mark
Affinity partitioning of lymphocytes in aqueous two-phase systems
1979) p.442-442(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Separation of leukocytes from human peripheral blood by countercurrent distribution in aqueous two-phase systems
(
- Contribution to journal › Published meeting abstract
- 1978
-
Mark
Separation of rat leukocytes by countercurrent distribution in aqueous two-phase systems
(
- Contribution to journal › Published meeting abstract
-
Mark
Separation of rat leukocytes by countercurrent distribution in aqueous two-phase systems. II. Subpopulations which mediate selective and nonselective lysis of normal and colon carcinoma target cells in vitro
(
- Contribution to journal › Article
-
Mark
Separation of rat leukocytes by countercurrent distribution in aqueous two-phase systems. I. Characterization of subpopulations of cells
(
- Contribution to journal › Article